|12-13-2018 04:25 AM CET - Advertising, Media Consulting, Marketing Research||
Congestive Heart Failure (CHF) Treatment Devices Market will reach 15400 million US$ in 2023
Press release from: Global Info Research
New report published by Global Info Research which offers insights on the global Congestive Heart Failure (CHF) Treatment Devices market.
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Click to view the full report TOC, figure and tables：
Global Congestive Heart Failure (CHF) Treatment Devices Market: Forecast by Type / Application / Region
This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.
The worldwide market for Congestive Heart Failure (CHF) Treatment Devices is expected to grow at a CAGR of roughly 5.7% over the next five years, will reach 15400 million US$ in 2023, from 11000 million US$ in 2017, according to a new GIR (Global Info Research) study.
Global Nonferrous Metal Recycling Market:Key Players
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International, Inc.
Jarvik Heart, Inc.
St. Jude Medical, Inc.
Ask for Discount on Research Report and Request Sample Copy of Report@
United States Congestive Heart Failure (CHF) Treatment Devices Market 2018 Forecast to 2023
Europe Congestive Heart Failure (CHF) Treatment Devices Market 2018 Forecast to 2023
North America Congestive Heart Failure (CHF) Treatment Devices Market 2018 Forecast to 2023
Asia-Pacific Congestive Heart Failure (CHF) Treatment Devices Market 2018 Forecast to 2023
China Congestive Heart Failure (CHF) Treatment Devices Market 2018 Forecast to 2023
EMEA Congestive Heart Failure (CHF) Treatment Devices Market 2018 Forecast to 2023
Global Congestive Heart Failure (CHF) Treatment Devices Market 2018 Forecast to 2023
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Contact US :
Sales Director (Global Info Research)
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong
This release was published on openPR.
News-ID: 1436724 • Views: 174More releases